Guardant Health (GH)
(Delayed Data from NSDQ)
$55.40 USD
+0.61 (1.11%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $56.09 +0.69 (1.25%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Guardant Health, Inc. has a market cap of $6.83B, which represents its share price of $54.79 multiplied by its outstanding shares number of 124.71M. As a mid-cap company, GH's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GH 55.40 +0.61(1.11%)
Will GH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GH
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
TMO Receives FDA Approval for Oncomine Dx Target Test
GH: What are Zacks experts saying now?
Zacks Private Portfolio Services
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
Other News for GH
NR7 appears for GH after 0.19% move
Guardant Health Director Makes Significant Stock Sale!
Insider Sell: Medina Hidalgo Sells 2,165 Shares of Guardant Health Inc (GH)
Guardant Health Expands Board, Appoints Alex Azar
The technical outlook for GH is unchanged after it falls 3.35% on September 12